Clinical trial
External Beam Radiotherapy and Zevalin for Management of Indolent B-Cell…
NCT00271050 · The Cleveland Clinic, Other · Completed
Key facts
| NCT number | NCT00271050 |
|---|---|
| Title | External Beam Radiotherapy and Zevalin for Management of Indolent B-Cell Non-Hodgkin's Lymphoma |
| Official title | The Role of Conformal External Beam Radiotherapy in the Management of Patients With Bulky Disease Undergoing Y90-Ibritumomab Tiuxetan (Zevalin) Radio-immunotherapy for Indolent B-cell Non-Hodgkin's Lymphoma |
| Lead sponsor | The Cleveland Clinic, Other |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Lymphoma, B-Cell |
| Intervention type | Other |
| Interventions | external beam radiotherapy plus 90-Y ibritumomab tiuxetan |
| Enrollment | 12 |
| Start date | Dec 1, 2005 |
| Primary completion | Dec 1, 2007 |
| Completion | Jun 1, 2010 |
| First posted | Dec 29, 2005 |
| Last update posted | Dec 21, 2010 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: